Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 14998 record(s)

Req # A-2024-000791

Adverse Drug Reaction (ADR) for Ondansetron. Report number: E2B_07292203.

Organization: Health Canada

65 page(s)
January 2025

Req # A-2024-000863

Adverse Drug Reaction (ADR). Report number: E2B_03172074.

Organization: Health Canada

220 page(s)
January 2025

Req # A-2024-000889

Adverse Drug Reaction (ADR). Report number: E2B_06977007.

Organization: Health Canada

10 page(s)
January 2025

Req # A-2024-001116

Adverse Drug Reaction (ADR). Report number: E2B_06483593.

Organization: Health Canada

721 page(s)
January 2025

Req # A-2024-001127

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-108016-770, Deputy Ministerial Meeting with the Food and Biologics Laboratories.

Organization: Health Canada

6 page(s)
January 2025

Req # A-2024-001180

Adverse Drug Reaction (ADR). Report number: E2B_07478904.

Organization: Health Canada

1105 page(s)
January 2025

Req # A-2024-001181

Adverse Drug Reactions (ADRs). Report numbers: E2B_07498406, E2B_07507896.

Organization: Health Canada

664 page(s)
January 2025

Req # A-2024-001189

Adverse Drug Reactions (ADRs). Report numbers: E2B_07458564, E2B_07467813.

Organization: Health Canada

1733 page(s)
January 2025

Req # A-2024-001212

Adverse Drug Reaction (ADR). Report number: E2B_07231496.

Organization: Health Canada

18 page(s)
January 2025

Req # A-2024-001227

Adverse Drug Reaction (ADR) for C1-Esterase Inhibitor. Report number: E2B_05862871.

Organization: Health Canada

30 page(s)
January 2025
Date modified: